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New and re-emerging infectious diseases with epidemic potential continue to cause much human 
and animal suffering worldwide.  Many new and re-emerging infectious diseases are zoonoses 
(infections occurring between humans and animals). The major impact of rapid geographical 
spread of infectious diseases is usually borne by developing countries as highlighted by the 2014-
2016 Ebola Virus (EboV) epidemic.  Once the infectious disease takes hold locally, it can spread 
rapidly within the region, and the rest of the world is put at equal risk due to weak health systems, 
ease of international travel, global food systems, livestock and wildlife trade and the poor 
international capacity to identify and respond quickly and effectively to disease outbreaks. The 
EBOLA epidemic and the emergence this century of previously unknown zoonotic respiratory tract 
infections with epidemic potential, including for example coronaviruses (MERS, SARS), highly 
pathogenic avian influenza viruses (HPAI-H5N1) highlights an urgent need to change the current 
global status quo and enable local, regional and international human and animal health systems to 
be more proactive, coordinated and better prepared to prevent another epidemic. 
 
All sub-Saharan African regions are highly biodiverse with approximately 80% of the population 
rural and highly dependent on livestock agriculture. Animal and human interactions are now more 
frequent. Movement of pathogens or potential pathogens between wild and domestic animals and 
people increases as the domestic populations expand, creating novel ecotones and ecosystemic 
perturbation (e.g. deforestation edge) explaining the rise in novel disease emergence such as EboV. 
As population rises food security demands, encourage intensification of livestock agriculture and 
this further enables evolution of novel zoonoses (HPAI, MERS-CoV) and their spill-over.   The scale 
and overwhelming effects of the recent EBOLA epidemic in West Africa clearly demonstrates the 
inter-connectedness of poverty related and neglected diseases with the profound negative impact it 
had on other infectious diseases national programs. Several lessons were learnt from the EboV 
outbreak that could help guide development of more effective and appropriate health response 
capacities in Africa.  The EboV epidemic aptly illustrated several failures of the current global status 
quo on outbreaks of infectious diseases with epidemic potential. The highly medicalized approach 
and ineffectiveness of the local and regional surveillance and alert mechanisms prevented or 
delayed appropriate socioecological management of the epidemic. Much of the spread and impact of 
EboV in West Africa was rooted in the emerging environmental, socioeconomic and 
socioanthropological changes taking place in this rapidly developing region of West Africa.  An 
apparent inability of the affected countries and WHO to act quickly, communicate effectively and 
mobilise communities was a critical factor in its spread. The poorly coordinated response by the 
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international community despite donor funds being available exacerbated this.  Better 
understanding of eco-epidemiological conditions ripe for the emergence and spread of disease, 
along with accurate case identification are key to effective outbreak control. Accurate, rapid field 
based diagnostic tests would have helped institute early interventions and screening for suspected 
cases. Absent were effective public health awareness and engagement, active disease surveillance, 
early diagnosis, rapid communication of data for health systems and communities to implement 
intervention or self-help measures are crucial components of controlling their spread.  The early 
response to the EboV epidemic was faced by the slowness of various stakeholders to share public 
health data in real time. Patients, HCWs and relatives were ostracised from their communities due 
to stigma. Improved understanding of socio-cultural and political determinants of infectious disease 
transmission, and effective implementation of interventions is required.  Behavioural factors also 
contributed to rapid outbreak spread and anthropological insights are essential to understand 
culturally acceptable way to address these needs in any future outbreak response. Foreign aid 
workers and research groups aroused local anxieties among communities due to ignorance of, or 
insensitivity to, cultural norms. Many healthcare workers (HCWs) lost their lives, thus risks for any 
outbreak need to be addressed to reduce healthcare worker morbidity and nosocomial 
transmission.  
 
The lack of local capacity and preparedness in affected West African countries to conduct 
comprehensive, multidisciplinary and well-coordinated research was also evident during the EboV 
epidemic. Research studies to evaluate and determine optimal management protocols and trial new 
treatments and vaccines were slow to start, and were dominated by foreign groups, with scanty 
involvement of African scientists or local policy makers. There is an urgent need to develop trusting 
partnerships between Africa and western countries and other stakeholders to take forward the 
model of developing equitable south-north partnerships for building effective outbreak response 
capacities in all African regions. Newer treatments under development and those under 
compassionate-use regulations were available but their usage and evaluation to inform optimal 
evidence-based management, were retarded by absence of rapid ethical review processes for 
research in emergency situations.  Thus an urgent need also exists for the establishment of a 
multidisciplinary consortium capable of provide accelerated evidence for the optimal clinical 
management of patients and for guiding the public health response to any severe infectious 
outbreak in Africa. 
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A more collaborative, inclusive and strategic ‘ONE HEALTH’ partnership between the human, 
environmental and animal health sectors is required to address emergent zoonotic threats 
effectively and improve current public health institutions' capabilities on disease preparedness, 
surveillance, and response. This will also enable issues around the growing threat of antimicrobial 
resistance (AMR) to be tackled. Whilst antibiotic resistant bacteria have spread globally due to 
increased travel and population movement, and migration, the problem of AMR in Africa remains 
largely undefined whilst access to appropriate antibiotics remains poor for the majority. The very 
recent WHO expert panel recommendations on AMR points out the lack of surveillance data and 
highlights the need for coordination between human and animal surveillance systems. Thus a 
multi-disciplinary consortium of human-animal-environmental ‘ONE HEALTH’ partners derived 
from existing human and animal health sectors in Africa is now essential for preventing another 
major epidemic in Africa. New opportunities now arise for this to be taken forward effectively as a 
pan-African ‘ONE HEALTH’ network. Post-Ebola African political commitment has dawned with the 
recent establishment of the African CDC. This coupled with the recent funding of four research and 
capacity development networks across Central, West, East and Southern funded by the European 
and Developing Countries Clinical Trials Partnership bring hope for a more consolidated and 
coordinated approach.  This involves numerous sub-Saharan African capacity development, 
research and training collaborative networks with extensive experience from work on TB, HIV, 
malaria and viral hemorrhagic fevers.  There are various strengths of this critical mass of pre-
existing resources, knowledge and capabilities.   
Based on a comprehensive 'inter-epidemic' work programme, they could develop a coherent, 
adequate and rapid interdisciplinary health response to emerging threats, a standardised 
methodological approach. This could involve identification and strengthening of suitable sites or 
regional networks, resolution of administrative, regulatory, disciplinary, ethical and cultural 
barriers, harmonise clinical case definitions and management guidelines, pre-approval of adaptable 
protocols, mechanisms to rapidly exchange high quality data and samples, etc.) that would ensure 
the readiness to immediately perform coordinated basic science research, define source of 
outbreak and transmission dynamics, and conduct large-scale multi-site clinical studies. 
Opportunities for establishing regional high quality laboratories and surveillance systems in Africa, 
span the full spectrum from baseline or current real time status information.   
 
Replicating the mobile laboratory model in all Africa regions will also enable to take forward the 
important agenda of establishing effective Rapid Response Team for outbreaks with support of 
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national governments and public health services.  Existing links with ongoing initiatives on 
emerging infections such as PREPARE (http://www.prepare-europe.eu/), ISARIC 
(https://isaric.tghn.org/ ), GLOPID-R  (Global Research Collaboration for Infectious Diseases 
Preparedness, (http://www.glopid-r.org/), WHO collaborating centres and regional WHO offices, 
OIE (World Organisation for Animal Health) and CHATHAM House will ensure smoother and 
quicker implementation of findings into optimal health guidelines, standards and policy 
recommendations.  Critically, links need to be developed between public health, veterinary, wildlife 
health and clinical laboratories. This is important to ensure the timeliness and quality of 
surveillance, research and response to zoonoses and the vexed issues of antimicrobial resistance in 
Africa. Benefits are not only accrued to public health but also food security and biodiversity 
conservation. Importantly, the future of health services in Africa will depend on empowering a 
whole generation of young African healthcare workers, scientists and technical staff to take 
leadership of emerging and re- emerging infections through high quality training and mentorship.  
The time is now ripe for Africa to take bold steps to develop its own capabilities and capacities to 
rapidly identify and respond quickly and effectively to potential outbreaks.  The challenge is now 
for African governments, scientists, public health personnel to take leadership of developing a new 
vision and strategy for the emerging and re-emerging infectious diseases and AMR portfolio across 
the continent. 
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Table/Figure 
Needs : Global Preparedness for New and Re-Emerging Infectious Disease Epidemic Threats    
1. Establishment of a ‘ONE animal-human-environmental HEALTH’ consortium to tackle 
emerging and re-emerging infections with epidemic potential and antimicrobial resistance with 
aims of:   
 i) Exploiting existing capabilities and capacities across human and animal health groups and 
develop cross cutting collaborations with synergy to have a multiplier effect.  
ii). Enhancing capacity to monitor local and regional Zoonotic and re-emerging diseases–trends, 
and for surveillance, predicting outbreaks and risk modelling, 
iii). Improved understanding of sociocultural and political determinants of infectious disease 
transmission, and effective implementation of interventions is required for vulnerable 
populations.  
iv). Engaging community leaders and defining social and cultural factors which influence patient 
acceptance of prevention and intervention measures. 
v). Developing local capacities for conduct of research: 
a). Multidisciplinary human and animal interface/infections research: (operational, 
anthropological, social science, basic science, translational clinical, clinical trials, implementation 
research) in two situations: 1). In the emergency outbreak or epidemic situation. 2). In the inter-
epidemic period.  
b). develop, evaluate, standardize and harmonize protocols for clinical management, laboratory, 
infection control and clinical trials 
vi). Develop capacities for rapid ethical review processes for research in emergency situations. 
2. Development of: 
i). Effective public health surveillance and laboratory, ethics and research capacities for the rapid 
investigation of outbreaks at source.  
ii). Mobile laboratories for field use across all four Africa regions with state of the art diagnostics 
capabilities including rapid sequencing and biopsy with histological analysis and PCR.   
iii). Regional, robust ‘ready to go (within 48-72 hours) outbreak rapid response teams, at each of 
the four African regions (Central, West, East and South) to assist when an outbreak occurs 
iv). Capacities for providing accelerated evidence for the optimal clinical management of patients 
and for guiding the public health response to any severe infectious outbreak.   
v).  ‘State of the art’ data management and communication systems and develop a common 
strategy for data collection, collation, analyses, integration, sharing and reporting at all four 
Africa regions.   
3: Empowerment by quality mentorship, of younger generation African scientists, clinicians, 
public health staff, healthcare workers, laboratory personnel, veterinarians, community workers, 
policy makers, and others to take leadership of this important portfolio of emerging infections. 
This will help sustain what is developed and will strengthen Africa’s ability to deal with emerging 
infections. This should include educational and training courses on infection control and the field 
epidemiology   
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4.  More effective political, policy maker and funder engagement - crucial for rapid action on 
surveillance alerts and clinical data on emerging diseases. To formally engage governments, 
policy makers and all stakeholders to develop a common plan, algorithms and protocols for a 
more coordinated response to outbreaks. Several African initiatives (African Union, SADAC, 
African CDC initiative, African Strategies for advancing Pathology Group, ASLM and others) need 
to work together for creation of local or regional surveillance and early outbreak response 
networks, and for increase awareness of AMR and the optimal ‘one health approach’ (animal and 
human health) to preventing zoonotic infections and AMR.  Harnessing other global 
organisations/initiaves eg: Chatam House-UK and UK-Public Health England, WHO-AFRO, Africa-
CDC, African country Ministries of Health, WHO-VIAG, WHO-GOARN, ISARIC, PREPARE, 
GloPiDSouth Africa, USAID-Africa Global Centre for Mass Gatherings Medicine,  to  ensure rapid 
dissemination of data/knowledge and more rapid action for future outbreaks. 
5. Need for good participatory practice and developing more trusting equitable and trusting 
south-north, and south-south partnerships on emerging and re-emerging infections.   
 
